The Cell-Specific Pattern of Cholecystokinin Peptides in Endocrine Cells Versus Neurons Is Governed by the Expression of Prohormone Convertases 1/3, 2, and 5/6
Open Access
- 20 December 2007
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (4) , 1600-1608
- https://doi.org/10.1210/en.2007-0278
Abstract
Most peptide hormone genes are, in addition to endocrine cells, also expressed in neurons. The peptide hormone cholecystokinin (CCK) is expressed in different molecular forms in cerebral neurons and intestinal endocrine cells. To understand this difference, we examined the roles of the neuroendocrine prohormone convertases (PC) 1/3, PC2, and PC5/6 by measurement of proCCK, processing intermediates and bioactive, α-amidated, and O-sulfated CCK peptides in cerebral and jejunal extracts of null mice, controls, and in the PC5/6-expressing SK-N-MC cell-line. In PC1/3 null mice, the synthesis of bioactive CCK peptide in the gut was reduced to 3% of the translational product, all of which was in the form of α-amidated and tyrosine O-sulfated CCK-22, whereas the neuronal synthesis in the brain was largely unaffected. This is opposite to the PC2 null mice in which only the cerebral synthesis was affected. SK-N-MC cells, which express neither PC1/3 nor PC2, synthesized alone the processing intermediate, glycine-extended CCK-22. Immunocytochemistry confirmed that intestinal endocrine CCK cells in wild-type mice express PC1/3 but not PC2. In contrast, cerebral CCK neurons contain PC2 and only little, if any, PC1/3. Taken together, the data indicate that PC1/3 governs the endocrine and PC2 the neuronal processing of proCCK, whereas PC5/6 contributes only to a modest endocrine synthesis of CCK-22. The results suggest that the different peptide patterns in the brain and the gut are due to different expression of PCs.Keywords
This publication has 45 references indexed in Scilit:
- Cholecystokinin Levels in Prohormone Convertase 2 Knock-out Mouse Brain Regions Reveal a Complex Phenotype of Region-specific AlterationsPublished by Elsevier ,2005
- CholecystokininBest Practice & Research Clinical Endocrinology & Metabolism, 2004
- Curbing activation: proprotein convertases in homeostasis and pathologyThe FASEB Journal, 2003
- Phylogeny of the Cholecystokinin/Gastrin FamilyFrontiers in Neuroendocrinology, 1998
- The proprotein convertasesCurrent Opinion in Chemical Biology, 1998
- Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein ConvertasesFrontiers in Neuroendocrinology, 1995
- Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1995
- Expression of the cholecystokinin gene in a human (small‐cell) lung carcinoma cell‐lineFEBS Letters, 1990
- Comparison of hepatic elimination of different forms of cholecystokinin in dogs. Bioassay and radioimmunoassay comparisons of cholecystokinin-8-sulfate and -33-sulfate.Journal of Clinical Investigation, 1985
- Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brainNature, 1978